Cumulative cefepime exposure in cancer patients is associated with an increased risk of ertapenem non-susceptible, meropenem susceptible Enterobacterales bacteremia.
Saved in:
| Title: | Cumulative cefepime exposure in cancer patients is associated with an increased risk of ertapenem non-susceptible, meropenem susceptible Enterobacterales bacteremia. |
|---|---|
| Authors: | Stabler AV; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shropshire WC; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Young A; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Feng C; Department of Pharmacy Quality-Regulatory, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hwang H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shelburne SA; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Vuong NN; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borjan J; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. |
| Source: | Microbiology spectrum [Microbiol Spectr] 2026 Apr 07; Vol. 14 (4), pp. e0278125. Date of Electronic Publication: 2026 Mar 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
